We are live on
!
Find out more
WCM
Wildcat Capital Management Portfolio holdings
AUM
$229M
1-Year Est. Return
132.65%
This Fund
S&P 500
This Quarter
Est. Return
+3.79%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$347M
AUM Growth
+$111M
(+47%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
33.17%
Top 10 Holdings %
Top 10 Hldgs %
79.95%
Holding
37
New
8
Increased
5
Reduced
7
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$78.4M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$9.58M |
| 3 |
Allogene Therapeutics
ALLO
|
+$8.14M |
| 4 |
PagSeguro Digital
PAGS
|
+$5.86M |
| 5 |
UroGen Pharma
URGN
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$5.37M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$3.24M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$3.07M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.56M |
| 5 |
OPTN
OptiNose
OPTN
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.78% |
| 2 | Healthcare | 24.18% |
| 3 | Real Estate | 16.81% |
| 4 | Energy | 9% |
| 5 | Consumer Discretionary | 4.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zoom
ZM
$28.2B
| $77.5M | 22.37% |
+1,139,755
| New | +$78.4M |
|
|
2
CoStar Group
CSGP
$11.7B
| $58.3M | 16.81% |
973,920
-92,050
| -9% | -$5.37M |
|
|
3
UroGen Pharma
URGN
$1.86B
| $38.6M | 11.13% |
1,155,862
+99,800
| +9% | +$2.72M |
|
|
4
Allogene Therapeutics
ALLO
$649M
| $31.2M | 9.01% |
1,201,826
+295,632
| +33% | +$8.14M |
|
5
Booking.com
BKNG
$149B
| $14.1M | 4.07% |
171,525
| – | – |
|
6
Meta Platforms (Facebook)
META
$1.42T
| $13.7M | 3.94% |
66,553
| – | – |
|
|
SBR
7
Sabine Royalty Trust
SBR
$1.06B
| $13.4M | 3.87% |
335,564
| – | – |
|
8
Magnolia Oil & Gas
MGY
$6.09B
| $10.8M | 3.1% |
854,997
-42,537
| -5% | -$476K |
|
9
Guidewire Software
GWRE
$12.6B
| $9.96M | 2.87% |
90,768
| – | – |
|
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $9.64M | 2.78% |
+110,120
| New | +$9.58M |
|
|
11
PagSeguro Digital
PAGS
$2.69B
| $8.7M | 2.51% |
254,686
+162,736
| +177% | +$5.86M |
|
12
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $8.01M | 2.31% |
70,189
-6,443
| -8% | -$728K |
|
|
13
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $7.84M | 2.26% |
61,428
-12,238
| -17% | -$1.56M |
|
14
Goosehead Insurance
GSHD
$2.2B
| $7.53M | 2.17% |
177,478
+31,400
| +21% | +$1.39M |
|
15
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $5.4M | 1.56% |
57,607
+22,630
| +65% | +$2.05M |
|
16
iShares National Muni Bond ETF
MUB
$45.1B
| $5M | 1.44% |
44,000
-41
| -0.1% | -$4.67K |
|
17
Cameco
CCJ
$37.6B
| $4.45M | 1.28% |
500,000
| – | – |
|
|
OPTN
18
DELISTED
OptiNose
OPTN
| $3.61M | 1.04% |
26,107
-8,443
| -24% | -$1.1M |
|
|
UROV
19
DELISTED
Urovant Sciences Ltd.
UROV
| $3.41M | 0.98% |
219,975
| – | – |
|
|
NCNA
20
NuCana
NCNA
$5.49M
| $3.22M | 0.93% |
105
| – | – |
|
21
Galicia Financial Group
GGAL
$7.99B
| $2.77M | 0.8% |
+170,379
| New | +$2.25M |
|
22
Aquestive Therapeutics
AQST
$463M
| $2.65M | 0.76% |
+455,358
| New | +$2.37M |
|
23
YPF
YPF
$206B
| $2.58M | 0.74% |
+222,685
| New | +$2.16M |
|
|
PLYA
24
DELISTED
Playa Hotels & Resorts
PLYA
| $2.52M | 0.73% |
300,000
| – | – |
|
|
GWPH
25
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $732K | 0.21% |
7,000
| – | – |
|
Similar funds
AFO
CNHF
GCM
CM
CSIA
AF
NIA
HFA
Wildcat Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Wildcat Capital Management held 37 positions worth $347M, up 47% from $235M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Wildcat Capital Management deployed $115M of net new capital in Q4 2019, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Zoom: 1,139,755 shares worth $77.5M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 7.3% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was CoStar Group, an estimated $5.37M trimmed.
- Wildcat Capital Management's largest Q4 2019 buy was Zoom: 1,139,755 shares worth $77.5M.
- Wildcat Capital Management added most to Allogene Therapeutics in Q4 2019, an estimated $8.14M increase.
- Wildcat Capital Management's biggest Q4 2019 reduction was CoStar Group, cutting an estimated $5.37M.
- Wildcat Capital Management fully exited Slack Technologies, Inc. in Q4 2019, selling an estimated $3.24M.
- Wildcat Capital Management's ten largest holdings make up 80% of its $347M portfolio in Q4 2019.
- Wildcat Capital Management opened 8 new positions and closed 7 in Q4 2019.
- Wildcat Capital Management's portfolio value rose 47% quarter-over-quarter to $347M.
Based on Wildcat Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.